Navigation Links
New partnership offers outsourced R&D in membrane biology
Date:9/24/2007

One of the UK's most successful academic entrepreneurs has teamed up with the University of Leeds to offer outsourced research and development in membrane biology to pharmaceutical, biotech and agrochemical companies.

Dr Tony Marchington, who turned his spin-out company Oxford Molecular into a business worth 450m, will work alongside the Universitys new Centre for Integrative Membrane Biology (CIMB) to broker research contracts with industry, based on Leeds world-class expertise in membrane biology.

Membrane biology research is central to the improved treatment of human disease with pharmaceutical drugs; currently around 75 per cent of current drugs have their effects via membrane proteins(1).

The partnership between CIMB, based at the Universitys Faculty of Biological Sciences, and M2 Ventures - Dr Marchingtons new company set up with finance expert Martin Manning - will offer a co-ordinated expert research resource to industry addressing membrane function at all levels: the biology of single cells through to whole organisms; analysis of protein structure and function; membranes on devices and high throughput interrogation platforms, such as for sensor technologies.

Says Dr Marchington: As the pharma and healthcare industries continue the trend to outsource their fundamental research and early stage development, the natural recipients of this work are universities, such as Leeds, that have both research excellence in these areas and can package and offer that expertise in ways that meet industry requirements.

Its self-evident that Leeds has exceptional breadth of expertise including world-class research capability in membrane biology; and as the market for targeted drugs accelerates, we believe that there will be great demand for their services. With our combined knowledge, experience and contacts, we are in a formidable position to capitalise on the strengths of this partnership.

The partnership was brokered by Leeds Professors Deborah Withington and John Colyer both of whom have extensive commercial experience. Professor Withington said: This partnership has all the hallmarks of something very special and were excited by its potential.


'/>"/>

Contact: Jo Kelly
jokelly@campuspr.co.uk
44-011-325-89880
University of Leeds
Source:Eurekalert

Related biology news :

1. Nonlinear Dynamics announces more details of its global partnership with PerkinElmer
2. New partnership to clear landmines for African Elephants
3. Gut microbes partnership helps body extract energy from food, store it as fat
4. Protein offers way to stop microscopic parasites in their tracks
5. World-first Living Donor Islet Cell Transplant A Success; Procedure Offers Promise For Diabetics
6. Gene silencing technique offers new strategy for treating, curing disease
7. Mosaic mouse technique offers a powerful new tool to study diseases and genetics
8. Drug Offers Alternative to Surgical Treatment After Miscarriage
9. Transgenic goats milk offers hope for tackling childrens intestinal disease
10. Engineered skin offers clues to melanoma development
11. GM crop that holds on to its seeds offers higher yields
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2019)... ... October 30, 2019 , ... PathSensors, Inc. ... Nashville, TN from Tuesday, November 5, 2019, to Thursday, November 7, 2019. This ... radiological, nuclear) and IED (explosive) threats. Delegates and experts from over 30 countries ...
(Date:10/29/2019)... , ... October 29, 2019 ... ... enterprise software solutions for biopharmaceutical R&D, today announced that Octapharma, one of ... platform to support the development and manufacturing of therapeutic proteins addressing ...
(Date:10/26/2019)... ... October 23, 2019 , ... Nanovis today announced that it ... FDA requirements for nanotechnology. , “We are delighted to receive such an ... role in achieving Nanovis’ goal to reduce the pain and suffering from implant ...
Breaking Biology News(10 mins):
(Date:11/12/2019)... ... November 12, 2019 , ... REPROCELL Inc. a ... selected by Lantern Pharma to provided preclinical screening and drug sensitivity for its ... points using panels of unique and genetically edited cell lines from various tumors. ...
(Date:11/12/2019)... (PRWEB) , ... November 12, 2019 , ... ... DNA services, welcomed their new Director of Forensic Genealogy, Melinde Lutz Byrne, to ... Service (FGS) to ultimately provide investigative leads to law enforcement through proven ...
(Date:11/6/2019)... ... ... Diversified Technologies, Inc. has introduced a PEF production system for ... processing. , The DTI Industrial PEF Unit can pre-treat whole pieces of fruits and ... up to 50% and achieve up to an 80% reduction of drying energy. ...
(Date:11/5/2019)... ... November 05, 2019 , ... Focal ... CE Mark for its Fusion Bx 2.0 prostate fusion biopsy solution. By combining ... Fusion Bx 2.0 will give urologists across Europe the ability to perform targeted ...
Breaking Biology Technology: